Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
Table 1
Comparison of general data in the two groups.
Low TT group
Normal TT group
75
138
Age (years)
53.25 ± 11.21
50.26 ± 11.38
0.382
Duration (months)
49.32 ± 52.14
53.77 ± 45.24
0.576
BMI (kg/m2)
27.32 ± 4.53
23.31 ± 3.64
0.021
WC (cm)
92.22 ± 9.45
83.36 ± 11.51
0.048
SBP (mmHg)
152.32 ± 34.25
149.62 ± 36.83
0.072
DBP (mmHg)
95.23 ± 18.35
96.39 ± 16.52
0.343
Complications
Diabetic nephropathy (%)
6 (8.0)
15 (10.8)
0.092
Diabetic retinopathy (%)
10 (14.3)
18 (13.0)
0.254
Diabetic neuropathy (%)
7 (9.3)
13 (9.4)
0.146
PAD (%)
12 (9.14)
17 (12.3)
0.096
CHD (%)
5 (6.7)
7 (5.1)
0.157
Cerebral infarction (%)
3 (4.0)
5 (3.6)
0.421
Comorbidities
NAFLD (%)
35 (52.2)
14 (29.1)
0.025
Hypertension (%)
49 (65.3)
82 (59.4)
0.983
Hypertriglyceridemia (%)
36 (48.0)
55 (39.8)
0.062
Low HDL-c (%)
37 (49.3)
56 (40.5)
0.125
Hyperuricemia (%)
16 (21.3)
22 (15.9)
0.071
Overweight or obesity (%)
50 (66.7)
68 (49.3)
0.036
Data are presented as the mean ± SD or the number of subjects in each group with percentages given in parentheses. The percentages were calculated based on the number of patients with evaluable data rather than the total eligible population. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; PAD, peripheral arterial disease; CHD, coronary heart disease; NAFLD, nonalcoholic fatty liver disease.
